Humana falls, Clover gains after Medicare quality ratings

Clover Health Investments

11/10/2024 09:42

** Shares in Humana  HUM.N  fall 3.7% while Clover Health
Investment  CLOV.O  gain 4.5% in premarket trade
    ** CLOV's PPO Medicare Advantage plans earn a 4-star rating
for 2025
    ** Humana is "likely to track in line" with its estimates
last week, which pointed to only a quarter of its members
remaining enrolled in 2025 for its 4+ rating plans, compared
with 94% in 2024, Oppenheimer said in a note
    ** The U.S. government said on Friday that 62% of people
currently enrolled in Medicare Advantage plans that cover
prescription drugs are covered by plans rated four or more stars
down from 74% last year
    ** About 40% of plans being offered are four stars or
higher, down from 42% in 2024, it added
    

    
  

 (Reporting by Paolo Laudani)
 ((Paolo.laudani@thomsonreuters.com))